Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
480
-
Total 13F shares, excl. options
-
91.2M
-
Shares change
-
-1.25M
-
Total reported value, excl. options
-
$9.32B
-
Value change
-
-$118M
-
Put/Call ratio
-
0.77
-
Number of buys
-
239
-
Number of sells
-
-179
-
Price
-
$102.15
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q3 2014
524 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q3 2014.
Edwards Lifesciences Corp - Common Stock (EW) has 480 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91.2M shares
of 590M outstanding shares and own 15.45% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (10.7M shares), VANGUARD GROUP INC (8.39M shares), Capital World Investors (5.98M shares), GENERATION INVESTMENT MANAGEMENT LLP (5.57M shares), FMR LLC (4.96M shares), State Street Corp (4.69M shares), WELLINGTON MANAGEMENT CO LLP (4.33M shares), BlackRock Institutional Trust Company, N.A. (2.78M shares), BlackRock Fund Advisors (1.62M shares), and NORTHERN TRUST CORP (1.42M shares).
This table shows the top 480 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.